<DOC>
	<DOCNO>NCT01816880</DOCNO>
	<brief_summary>The aim sub-study determine whether healthy individual 90 year age posse immune cell involve protection chronic disease . The immune system well know produce anti-cancer immune cell , call antibody beneficial health . In study investigator evaluate immune status healthy individual 90 year age . The investigator focus study molecule know involved cholesterol , cancer like prostate cancer breast cancer , inflammatory disease , infectious disease like influenza .</brief_summary>
	<brief_title>Wellderly Immune Antibodies Study , Sub-Study Healthy Elderly Active Longevity ( HEAL ) Cohort</brief_title>
	<detailed_description>The aim sub-study determine whether Wellderly pose neutralize antibody target antigen involve chronic disease . The humoral immune system well know produce anti-cancer antibody long live vivo . In study evaluate antibody status Wellderly respect neutralizing ( ) molecules know induce cholesterol like PCSK9 , ( ii ) antibodies cancer antigen like PMSA ( prostate cancer ) Her2 ( Breast cancer ) , ( iii ) antibodies inflammatory molecule like TNFa IL-6 , ( iv ) antibodies broad neutralizing activity infectious disease like influenza .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Age 90 2 . Gender : Male Female 3 . Enrolled Healthy Elderly ( HEAL ) study prior enrollment substudy 4 . Eligible Blood draw 5 . Be reliable , cooperative willing comply protocolspecified procedure . 6 . Able understand grant inform consent 7 . Be healthy mild medical condition may associate normal age process , include : Hypertension , well control 3 medication Osteoporosis Osteopenia Osteoarthritis Benign Prostatic Hypertrophy Cataracts , Glaucoma Macular Degeneration Dyslipidemia Hypothyroidism PreDiabetes/Impaired Fasting Glucose ( fast blood glucose 100126 mg/dL , know ) Basal Squamous Cell Carcinoma Individuals exclude ANY follow condition apply : EXCLUSION CRITERIA 1 . Less 90 year age 2 . Currently undergo treatment investigational agent device within 30 precede enrollment study . 3 . Selfreported history current diagnosis significant chronic condition include : Any Cancer ( include polycythemia ; exclude basal squamous cell carcinoma Coronary Artery Disease , Myocardial Infarction Stroke Transient Ischemic Attack ( TIA ) Deep Vein Thrombosis Pulmonary Embolism Chronic Renal Disease Hemodialysis Significant AutoImmune Inflammatory condition Rheumatoid Arthritis , Lupus , Crohn 's Disease , etc . Alzheimer 's Parkinson 's Disease Diabetes ( Hemoglobin A1C &gt; 6.5 % fast glucose &gt; 126 mg/dL treat insulin oral diabetic medication Aortic Cerebral Aneurysm 4 . Currently take follow medication regular basis : Chemotherapeutic agent ( ex . Tamoxifen , Doxorubicin , Mitoxantrone , bleomycin Antiplatelet anticoagulant agent , include Aspirin ( ex . Clopidogrel/Plavix , Dipyridamole/Aggrenox/Persantine , Ticlopidine/Ticlid , Warfarin/Coumadin , Prasugrel , etc . ) Cholinesterase inhibitor Alzheimer 's disease ( ex . Donzepril/Aricept ) Insulin oral diabetic medication 5 . Individual significant medical condition , investigator 's opinion , may interfere individual 's optimal participation study would potentially confound interpretation individual 's phenotype .</criteria>
	<gender>All</gender>
	<minimum_age>90 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>